Tetraphase Pharmaceuticals Inc. (TTPH)

1.29
0.10 7.19
NASDAQ : Health Technology
Prev Close 1.39
Open 1.39
Day Low/High 1.28 / 1.40
52 Wk Low/High 1.01 / 6.62
Volume 1.04M
Avg Volume 627.70K
Exchange NASDAQ
Shares Outstanding 53.63M
Market Cap 74.54M
EPS -2.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
Tetraphase Executive Profits Hours Before Stock Plummets

Tetraphase Executive Profits Hours Before Stock Plummets

A Tetraphase insider executed a well-timed insider stock sale right before the company's share price fell on negative clinical trial results.

Today's Dead Cat Bounce Stock Is Tetraphase Pharmaceuticals (TTPH)

Today's Dead Cat Bounce Stock Is Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Market Wrap: Giving It All Back and Then Some

U.S. stock finished in the red across the board after early gains.

Tetraphase Pharmaceuticals (TTPH) Stock Tanks on Weak Phase 3 Test Results

Tetraphase Pharmaceuticals (TTPH) Stock Tanks on Weak Phase 3 Test Results

Tetraphase Pharmaceuticals (TTPH) shares are down nearly 80% after the company announced that its urinary tract infection treatment failed a phase 3 test.

Analysts' Actions -- Mannkind, Micron, Ciena, Finisar and More

Analysts' Actions -- Mannkind, Micron, Ciena, Finisar and More

Here are Wednesday's top research calls, including ratings changes for Mannkind, Micron, Ciena and Finisar.

Today's Pre-Market Mover With Heavy Volume: Tetraphase Pharmaceuticals (TTPH)

Today's Pre-Market Mover With Heavy Volume: Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a pre-market mover with heavy volume candidate

Tuesday's Clinical Trial Scorecard: Akebia Wins, Tetraphase, Flexion, Theravance Lose

Tuesday's Clinical Trial Scorecard: Akebia Wins, Tetraphase, Flexion, Theravance Lose

Four biotech companies announced important clinical trials results Tuesday at market close.

First Week of TTPH October 16th Options Trading

First Week of TTPH October 16th Options Trading

Investors in Tetraphase Pharmaceuticals, Inc saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TTPH options chain for the new October 16th contracts and identified one put and one call contract of particular interest.

Tetraphase Pharmaceuticals Reports Second-Quarter 2015 Financial Results

Tetraphase Pharmaceuticals Reports Second-Quarter 2015 Financial Results

Company to Host Conference Call at 4:30 p.m. ET Today

Tetraphase Pharmaceuticals (TTPH) Is Weak On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Is Weak On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Tetraphase Pharmaceuticals (TTPH) Is Today's Strong On High Volume Stock

Tetraphase Pharmaceuticals (TTPH) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a strong on high relative volume candidate

Tetraphase Pharmaceuticals (TTPH) Hits New Lifetime High

Tetraphase Pharmaceuticals (TTPH) Hits New Lifetime High

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a new lifetime high candidate

Tetraphase Pharmaceuticals (TTPH) Strong On High Relative Volume Today

Tetraphase Pharmaceuticals (TTPH) Strong On High Relative Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a strong on high relative volume candidate

Playing Biotechs with the House's Money

Playing Biotechs with the House's Money

Here's how to lock in gains on risky small-cap biotechnology stocks.

4 Momentum Stocks Breaking Out and Poised to Move Higher

4 Momentum Stocks Breaking Out and Poised to Move Higher

Buy these four momentum stocks for strong gains over the next several months.

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Trade-Ideas: Tetraphase Pharmaceuticals (TTPH) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas: Tetraphase Pharmaceuticals (TTPH) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Failed Bounce Brings Selling Pressure

Oil prices and energy funds slide.

Short Interest In Tetraphase Pharmaceuticals Increases 25.4%

Short Interest In Tetraphase Pharmaceuticals Increases 25.4%

The most recent short interest data has been released by the NASDAQ for the 04/15/2015 settlement date, which shows a 552,149 share increase in total short interest for Tetraphase Pharmaceuticals, Inc , to 2,727,787, an increase of 25.38% since 03/31/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

TheStreet Quant Rating: D (Sell)